In contrast, the loss of PTEN occurs in 55% of GCB-DLBCLs, and AKT activation in GCB-DLBCL cells is frequently associated with the PTEN loss, which makes tumor cells addicted to oncogenic PI3K signaling [7]. The gene discussed is PTEN; the disease is neoplasm.